Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-028420
Filing Date
2025-02-18
Accepted
2025-02-18 13:03:36
Documents
15
Period of Report
2025-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d925657d8ka.htm   iXBRL 8-K/A 28604
2 EX-99.1 d925657dex991.htm EX-99.1 22009
6 GRAPHIC g925657g0218215506412.jpg GRAPHIC 2849
  Complete submission text file 0001193125-25-028420.txt   191313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20250218.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20250218_lab.xml EX-101.LAB 18702
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20250218_pre.xml EX-101.PRE 11706
17 EXTRACTED XBRL INSTANCE DOCUMENT d925657d8ka_htm.xml XML 4777
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39103 | Film No.: 25633993
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)